Latest filing published 20 Nov 2025 for Oncology Institute, Inc..
Filing timeline
BuySaleInsider track record
M33 Growth I L.P.: trading record in brief
This profile gathers the share dealings of M33 Growth I L.P. in Starling Oncology, Inc. The record holds 10 filings, for trades running from 26 March 2025 to 18 November 2025.
The open-market record consists of 6 sales worth €24.6M, with no purchase. Besides market trades, the filings include 1 share grant.
The record was last updated on 20 November 2025 with a transaction in Starling Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to M33 Growth I L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 590,892 sharesCommon StockSEC:0001213900-25-113113:0
- 6,018,168 shares@ US$3.0964.6% of flowCommon StockSEC:0001213900-25-084700:0
- 673,676 shares@ US$3.057.3% of flowCommon StockSEC:0001213900-25-052626:0
- 1,796,468 shares@ US$2.712917.5% of flowCommon StockSEC:0001213900-25-046977:0
- 2,716,898 shares@ US$1.041710.6% of flowCommon StockSEC:0001013762-25-004330:0
5 of 5 declarations
